Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 6/2002

01-06-2002

Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence

Authors: Tilman M. Bauer, Antonio Follo, Miguel Navasa, Jordi Vila, Ramon Planas, Gerardo Clemente, Victor Vargas, Felipe Bory, Pere Vaquer, Juan Rodés

Published in: Digestive Diseases and Sciences | Issue 6/2002

Login to get access
Metadata
Title
Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence
Authors
Tilman M. Bauer
Antonio Follo
Miguel Navasa
Jordi Vila
Ramon Planas
Gerardo Clemente
Victor Vargas
Felipe Bory
Pere Vaquer
Juan Rodés
Publication date
01-06-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 6/2002
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1015386901343

Other articles of this Issue 6/2002

Digestive Diseases and Sciences 6/2002 Go to the issue

OriginalPaper

Experimental Colitis Attenuates Development of Toxin-Induced Cholangitis in Rats

OriginalPaper

Dietary Iron Supplementation Enhances DSS-Induced Colitis and Associated Colorectal Carcinoma Development in Mice

BriefCommunication

CASE REPORT: Anaphylaxis-Like Reaction to Infliximab in a Patient with Crohn's Disease

OriginalPaper

Effect of Acid Perfusion on Passive Electrophysiological Properties of Rabbit Esophagus In Vivo

OriginalPaper

Short-Term Intestinal Ischemia–Reperfusion Alters Intestinal Motility That Can Be Preserved by Xanthine Oxidase Inhibition

OriginalPaper

Diagnosis of Nutcracker Esophagus, Segmental or Diffuse Hypertensive Patterns, and Clinical Characteristics
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits